Skip to content

Clinical trials

Completed Phase 1 Gastroesophageal Reflux trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 1 Status: Completed Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20063
20073
20088
20094
20104
20111
20121
20135
20145
20176
20183
20191
20203
20214
20224
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Takeda6
Addpharma Inc.4
Chong Kun Dang Pharmaceutical4
Cinclus Pharma Holding AB3
Phathom Pharmaceuticals, Inc.3
University of North Carolina, Chapel Hill3
Janssen Research & Development, LLC2
Jiangsu Sinorda Biomedicine Co., Ltd2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux65
Heartburn5
Esophagitis3
Barrett Esophagus2
Laryngopharyngeal Reflux2
Obesity2
Stomach Ulcer2
Duodenal Ulcer1
Esophagitis, Peptic1
Gastrointestinal Neoplasms1

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.